NVIVQ — InVivo Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00Brief: Invivo Therapeutics Provides Enrollment Update For Inspire 2.0 Study For The Treatment Of Acute Spinal Cord Injury
Brief: Invivo Therapeutics Holdings Receives Deficiency Letter From Listing Qualifications Department Of Nasdaq
Brief: Invivo Therapeutics Announces Publication Of Contempo Registry Study Data
Brief: Invivo Therapeutics Announces Postponement Of Annual Meeting
Brief: Invivo Therapeutics Announces Adjournment Of Annual Meeting
Brief: InVivo Therapeutics Posts Presentation Of Twelve-Month Results From The INSPIRE Study Of The Investigational Neuro-Spinal Scaffold
Brief: Invivo Therapeutics Reports 2018 Year-End Financial Results And Provides Business Update
Brief: Invivo Therapeutics Announces Appointment Of Richard Christopher As CFO
Brief: Invivo Therapeutics Says Co Anticipates Enrolling First Patient In Inspire 2.0 Study In Q1 2019
Brief: Invivo Therapeutics Holdings Reports Q3 Loss Per Share Of $0.42
Brief: Invivo Therapeutics Announces Joint Research Collaboration With Q Therapeutics
Brief: Invivo Therapeutics Announces 12-Month Data From Inspire Study
Brief: Invivo Therapeutics Holdings Says Received Notification Co Was Not In Compliance With Nasdaq Listing Rule On Aug.15
Brief: Invivo Therapeutics Reports Q2 Loss Per Share Of $7.48
InVivo: Hits record low on public offering
Brief: Invivo Therapeutics Announces Pricing Of $13.2 Mln Public Offering
U.S. STOCKS ON THE MOVE-Darden, Kroger, Limoneira, ZTO Express, CASI
U.S. STOCKS ON THE MOVE-Micron, Darden, Kroger, American Outdoor
U.S. STOCKS ON THE MOVE-ObsEva, Valeant, Zillow, Baytex, Intel